{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:14:10Z","timestamp":1754144050621,"version":"3.41.2"},"reference-count":47,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Can. J. Aging"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Behavioural treatments are recommended first-line for insomnia, but long-term benzodiazepine receptor agonist (BZRA) use remains common and engaging patients in a deprescribing consultation is challenging. Few deprescribing interventions directly target patients. Prescribers\u2019 support of patient-targeted interventions may facilitate their uptake. Recently assessed in the Your Answers When Needing Sleep in New Brunswick (YAWNS NB) study, Sleepwell (mysleepwell.ca) was developed as a direct-to-patient behaviour change intervention promoting BZRA deprescribing and non-pharmacological insomnia management. BZRA prescribers of YAWNS NB participants were invited to complete an online survey assessing the acceptability of Sleepwell as a direct-to-patient intervention. The survey was developed using the seven construct components of the theoretical framework of acceptability (TFA) framework. Respondents (40\/250, 17.2%) indicated high acceptability, with positive responses per TFA construct averaging 32.3\/40 (80.7%). Perceived as an ethical, credible, and useful tool, Sleepwell also promoted prescriber\u2013patient BZRA deprescribing engagements (11\/19, 58%). Prescribers were accepting of Sleepwell and supported its application as a direct-to-patient intervention.<\/jats:p>","DOI":"10.1017\/s0714980824000114","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T04:24:27Z","timestamp":1709871867000},"page":"529-537","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":2,"title":["Prescriber Acceptability of a Direct-to-Patient Intervention for Benzodiazepine Receptor Agonist Deprescribing and Behavioural Management of Insomnia in Older Adults"],"prefix":"10.1017","volume":"43","author":[{"given":"Andrea L.","family":"Murphy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin P.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malgorzata","family":"Rajda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen G.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0980-6399","authenticated-orcid":false,"given":"David M.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2024,3,8]]},"reference":[{"key":"S0714980824000114_r10","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/hex.12119","article-title":"Patients\u2019 and clinicians\u2019 experiences and perceptions of the primary care management of insomnia: Qualitative study","volume":"18","author":"Davy","year":"2015","journal-title":"Health Expectations"},{"key":"S0714980824000114_r21","doi-asserted-by":"crossref","first-page":"100164","DOI":"10.1016\/j.rcsop.2022.100164","article-title":"A protocol for a randomized controlled trial comparing Sleepwell, EMPOWER, and treatment-as-usual for benzodiazepine receptor agonist discontinuation in older adults: The your answers when needing sleep in New Brunswick (YAWNS NB) study","volume":"7","author":"Murphy","year":"2022","journal-title":"Exploratory Research in Clinical and Social Pharmacy"},{"key":"S0714980824000114_r2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/npr2.12219","article-title":"Development and acceptability of a decision aid for chronic insomnia considering discontinuation of benzodiazepine hypnotics","volume":"42","author":"Aoki","year":"2021","journal-title":"Neuropsychopharmacology Reports"},{"key":"S0714980824000114_r14","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"Journal of Biomedical Informatics"},{"key":"S0714980824000114_r28","first-page":"835","article-title":"Educating physicians to reduce benzodiazepine use by elderly patients: A randomized controlled trial","volume":"168","author":"Pimlott","year":"2003","journal-title":"CMAJ: Canadian Medical Association Journal"},{"key":"S0714980824000114_r41","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.2196\/jmir.8561","article-title":"Effect of recruitment methods on response rate in a web-based study for primary care physicians: Factorial randomized controlled trial","volume":"20","author":"So","year":"2018","journal-title":"Journal of Medical Internet Research"},{"key":"S0714980824000114_r18","first-page":"36","article-title":"Reducing benzodiazepine prescribing in older veterans: A direct-to-consumer educational brochure","volume":"35","author":"Mendes","year":"2018","journal-title":"Federal Practitioner"},{"key":"S0714980824000114_r4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/phn.13153","article-title":"Building consensus in defining and conceptualizing acceptability of healthcare: A Delphi study","volume":"40","author":"Bucyibaruta","year":"2023","journal-title":"Public Health Nursing"},{"key":"S0714980824000114_r15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) \u2013\u00a0A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"Journal of Biomedical Informatics"},{"key":"S0714980824000114_r25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: Version 2","volume":"44","author":"O\u2019Mahony","year":"2015","journal-title":"Age and Ageing"},{"key":"S0714980824000114_r12","article-title":"Benzodiazepine use and risk of incident dementia or cognitive decline: Prospective population based study","volume":"352","author":"Gray","year":"2016","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"S0714980824000114_r42","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/gps.5048","article-title":"Benzodiazepines or related drugs and risk of pneumonia: A systematic review and meta-analysis","volume":"34","author":"Sun","year":"2019","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"S0714980824000114_r23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12875-019-0965-0","article-title":"Physicians\u2019 beliefs and attitudes about Benzodiazepines: A cross-sectional study","volume":"20","author":"Neves","year":"2019","journal-title":"BMC Family Practice"},{"key":"S0714980824000114_r13","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1007\/s11606-020-06493-8","article-title":"Patient and physician perspectives of deprescribing potentially inappropriate medications in older adults with a history of falls: A qualitative study","volume":"36","author":"Hahn","year":"2021","journal-title":"Journal of General Internal Medicine"},{"key":"S0714980824000114_r43","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1017\/S1041610211002031","article-title":"Assessing the cumulative effects of exposure to selected benzodiazepines on the risk of fall-related injuries in the elderly","volume":"24","author":"Sylvestre","year":"2012","journal-title":"International Psychogeriatrics\/IPA"},{"key":"S0714980824000114_r22","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/pds.4028","article-title":"The association between benzodiazepines and influenza-like illness-related pneumonia and mortality: A survival analysis using UK primary care data","volume":"25","author":"Nakafero","year":"2016","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"S0714980824000114_r16","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/add.14981","article-title":"Brief interventions targeting long\u2010term benzodiazepine and Z\u2010drug use in primary care: A systematic review and meta\u2010analysis.","volume":"115","author":"Lynch","year":"2020","journal-title":"Addiction"},{"key":"S0714980824000114_r38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1471-2296-14-191","article-title":"General practitioners\u2019 experiences and perceptions of benzodiazepine prescribing: Systematic review and meta-synthesis","volume":"14","author":"Sirdifield","year":"2013","journal-title":"BMC Family Practice"},{"key":"S0714980824000114_r44","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","article-title":"Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: The EMPOWER cluster randomized trial","volume":"174","author":"Tannenbaum","year":"2014","journal-title":"JAMA Internal Medicine"},{"key":"S0714980824000114_r47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/pharmacy6020031","article-title":"Does a consumer-targeted deprescribing intervention compromise patient-healthcare provider trust?","volume":"6","author":"Zhang","year":"2018","journal-title":"Pharmacy"},{"key":"S0714980824000114_r27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13104-021-05895-z","article-title":"Survey participation among general practitioners: Comparison between teaching physicians and a random sample","volume":"15","author":"Pentzek","year":"2022","journal-title":"BMC Research Notes"},{"key":"S0714980824000114_r9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5770\/cgj.23.419","article-title":"Canadian guidelines on benzodiazepine receptor agonist use disorder among older adults","volume":"23","author":"Conn","year":"2020","journal-title":"Canadian Geriatrics Journal"},{"key":"S0714980824000114_r20","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.2009.682","article-title":"Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: A randomized controlled trial","volume":"301","author":"Morin","year":"2009","journal-title":"JAMA"},{"key":"S0714980824000114_r35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12913-017-2031-8","article-title":"Acceptability of healthcare interventions: An overview of reviews and development of a theoretical framework","volume":"17","author":"Sekhon","year":"2017","journal-title":"BMC Health Services Research"},{"key":"S0714980824000114_r37","first-page":"39","article-title":"Policies for deprescribing: An international scan of intended and unintended outcomes of limiting sedative-hypnotic use in community-dwelling older adults","volume":"14","author":"Shaw","year":"2019","journal-title":"Healthcare Policy"},{"key":"S0714980824000114_r24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40266-018-0544-4","article-title":"Deprescribing benzodiazepines in older patients: Impact of interventions targeting physicians, pharmacists, and patients","volume":"35","author":"Ng","year":"2018","journal-title":"Drugs and Aging"},{"key":"S0714980824000114_r32","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/metabo11040254","article-title":"The barriers and facilitators of different stakeholders when deprescribing benzodiazepine receptor agonists in older patients\u2014A systematic review","volume":"11","author":"Rasmussen","year":"2021","journal-title":"Metabolites"},{"key":"S0714980824000114_r5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/10600280211033022","article-title":"Addressing barriers to reducing prescribing and implementing deprescribing of sedative-hypnotics in primary care","volume":"56","author":"Burry","year":"2022","journal-title":"Annals of Pharmacotherapy"},{"key":"S0714980824000114_r30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","article-title":"Outcomes for implementation research: Conceptual distinctions, measurement challenges, and research agenda","volume":"38","author":"Proctor","year":"2011","journal-title":"Administration and Policy in Mental Health"},{"key":"S0714980824000114_r29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40360-015-0019-8","article-title":"Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: A scoping review","volume":"16","author":"Pollmann","year":"2015","journal-title":"BMC Pharmacology and Toxicology"},{"key":"S0714980824000114_r33","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00228-017-2257-8","article-title":"A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people","volume":"73","author":"Reeve","year":"2017","journal-title":"European Journal of Clinical Pharmacology"},{"key":"S0714980824000114_r3","first-page":"493","article-title":"Benzodiazepines and Z-Drugs: An updated review of major adverse outcomes reported on in epidemiologic research","volume":"17","author":"Brandt","year":"2017","journal-title":"Drugs in RandD"},{"key":"S0714980824000114_r34","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/15389588.2013.830211","article-title":"Meta-analysis of on-the-road experimental studies of hypnotics: Effects of time after intake, dose, and half-life","volume":"15","author":"Roth","year":"2014","journal-title":"Traffic Injury Prevention"},{"key":"S0714980824000114_r6","unstructured":"Canadian Deprescribing Network. (2017). Canadian Deprescribing Network 2017 Annual Report (pp. 1\u201319). Retrieved from https:\/\/www.deprescribingnetwork.ca\/reports."},{"key":"S0714980824000114_r36","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1007\/s11606-021-06737-1","article-title":"A consensus-based checklist for reporting of survey studies (CROSS)","volume":"36","author":"Sharma","year":"2021","journal-title":"Journal of General Internal Medicine"},{"key":"S0714980824000114_r40","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2165\/11533170-000000000-00000","article-title":"The relationship between benzodiazepine use and traffic accidents: A systematic literature review","volume":"24","author":"Smink","year":"2010","journal-title":"CNS Drugs"},{"key":"S0714980824000114_r31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.7326\/M15-2175","article-title":"Management of chronic insomnia disorder in adults: A clinical practice guideline from the American College of Physicians","volume":"165","author":"Qaseem","year":"2016","journal-title":"Annals of Internal Medicine"},{"key":"S0714980824000114_r11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/jcpt.12688","article-title":"How confident are physicians in deprescribing for the elderly and what barriers prevent deprescribing?","volume":"43","author":"Djatche","year":"2018","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"volume-title":"Overuse of tests and treatments in Canada\u2014Methodology notes","year":"2022a","key":"S0714980824000114_r7"},{"key":"S0714980824000114_r19","doi-asserted-by":"crossref","first-page":"e13017","DOI":"10.1111\/jsr.13017","article-title":"Cognitive behavioural therapy for insomnia (CBTi): From randomized controlled trials to practice guidelines to implementation in clinical practice","volume":"29","author":"Morin","year":"2020","journal-title":"Journal of Sleep Research"},{"key":"S0714980824000114_r17","doi-asserted-by":"crossref","first-page":"e015959","DOI":"10.1136\/bmjopen-2017-015959","article-title":"A realist evaluation of patients\u2019 decisions to deprescribe in the EMPOWER trial","volume":"7","author":"Martin","year":"2017","journal-title":"BMJ Open"},{"key":"S0714980824000114_r46","doi-asserted-by":"crossref","first-page":"e1003983","DOI":"10.1371\/journal.pmed.1003983","article-title":"Evaluation of a multicomponent intervention consisting of education and feedback to reduce benzodiazepine prescriptions by general practitioners: The BENZORED hybrid type 1 cluster randomized controlled trial","volume":"19","author":"Vicens","year":"2022","journal-title":"PLoS Medicine"},{"key":"S0714980824000114_r26","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2165\/00002512-200320110-00004","article-title":"The costs of benzodiazepine-associated hospital-treated fall Injuries in the EU: A Pharmo study","volume":"20","author":"Panneman","year":"2003","journal-title":"Drugs and Aging"},{"key":"S0714980824000114_r45","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s41999-022-00702-9","article-title":"Deprescribing practices, habits and attitudes of geriatricians and geriatricians-in-training across Europe: A large web-based survey","volume":"13","author":"van Poelgeest","year":"2022","journal-title":"European Geriatric Medicine"},{"volume-title":"Overuse of tests and treatments in Canada\u2014Progress report","year":"2022b","key":"S0714980824000114_r8"},{"key":"S0714980824000114_r39","unstructured":"Sleepwell | It\u2019s no dream. Sleep well without sleeping pills. (2023). Retrieved April 11, 2023, from Sleepwell website: https:\/\/mysleepwell.ca\/"},{"key":"S0714980824000114_r1","doi-asserted-by":"crossref","first-page":"e006544","DOI":"10.1136\/bmjopen-2014-006544","article-title":"Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: A systematic review and thematic synthesis","volume":"4","author":"Anderson","year":"2014","journal-title":"BMJ Open"}],"container-title":["Canadian Journal on Aging \/ La Revue canadienne du vieillissement"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0714980824000114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T06:02:41Z","timestamp":1752559361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0714980824000114\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,8]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0714980824000114"],"URL":"https:\/\/doi.org\/10.1017\/s0714980824000114","relation":{},"ISSN":["0714-9808","1710-1107"],"issn-type":[{"type":"print","value":"0714-9808"},{"type":"electronic","value":"1710-1107"}],"subject":[],"published":{"date-parts":[[2024,3,8]]},"assertion":[{"value":"\u00a9 Canadian Association on Gerontology 2024","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}